20. Evolution and Ecology Part II Flashcards
Evolution of SARS-CoV-2 Delta variant:
-first detected in Dec 2020 in India
-UK first case in March 2021
*replaces alpha in March 2021=EVOLUTION
-odds of household transmission 70% higher than alpha
>less than 3% of people fully vaccinated
Delta viral load over infection:
-higher viral loads over duration of infection compared to other variants
R0 of Delta:
-R0=5-10 (compared to 1-3)
-more transmissible and more competitive than ancestral strains
>replaced them in a few months
*evolution by natural selection has produced a ‘fitter’ pathogen
Widespread use of antimicrobials in food animals and human medicine:
-has caused bacteria to EVOLVE antimicrobial resistance (AMR)
Evolution of AMR occurs through:
-natural selection
Antibiotic resistance scenario:
-person infected with bacterial pathogen is treated with antibiotic drug
-drug kills most bacteria, but some mutants carry an AMR gene that protects them
-mutant reproduces and passes AMR gene on
-patient carries a drug-resistant population of bacteria: patient recovers
*AMR bacteria are transmitted to other patients in hospital (or animal herd)
AMR evolution:
-happens very quickly
-percentage of Enterobacteriacea strains resistant to 10 antibiotics increased!
>Salmonella, E.coli, Klebsiella and Shingella
Penicillin resistance vs. penicillin usage:
-penicillin tested on pneumococci cultured from human patients
-N. EU has strict regulations
-S. EU less strict
*resistance to pencillin in pneumococci is higher in S vs. N. EU
AMR bacteria (‘superbugs’) in Europe kills:
-around 33,000 people across Europe each year
-variation in countries is mostly due to differences in population size
AMR bacteria worldwide kill:
-700,000 people/year
-10million by 2050
*evolving faster than science is inventing new antibiotics
Discovery of new antibiotics has stopped:
-no treatment options for some bacterial infections
-1987 was the last discovery of new marketable class
*bacterial infections are becoming harder to treat worldwide (DISCOVERY VOID)
Antimicrobial use in Canada in 2016:
-Canada is a major food producer
-19x more domestic animals than humans
*4x more antibiotics for animals than humans
Antimicrobial use in Canada in 2016 by sector:
-20% humans
-78% production animals (cattle, pigs, poultry)
-1% companion animals
Health Canada’s 4 categories for antimicrobials of importance for human medicine:
- Very high
- High
- Medium
- Low
Class 1 antimicrobial drugs:
-restricted to humans and domestic animals
Ex. cephalosporins, fluroquinolones
Class 2 antimicrobial drugs:
-used in all 3 sectors
Ex. penicillin, lincosamides, marcolides
Class 3 antimicrobial drugs:
-used in food animals
Ex. tetracycline
*food production might not be as responsible for AMR